Poor past and look forward
Open Access
- 17 July 2021
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (4), 2930
- https://doi.org/10.15829/1728-8800-2021-2930
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold ResorptionJournal of the American College of Cardiology, 2019
- Bioresorbable ScaffoldsJournal of the American College of Cardiology, 2019
- Three-Year Outcomes With the Absorb Bioresorbable ScaffoldJournal of the American College of Cardiology, 2018
- Device Thrombosis with Bioresorbable ScaffoldsThe New England Journal of Medicine, 2017
- Bioresorbable Scaffolds versus Metallic Stents in Routine PCIThe New England Journal of Medicine, 2017
- Mid-term and long-term safety and efficacy of bioresorbable vascular scaffolds versus metallic everolimus-eluting stents in coronary artery disease: A weighted meta-analysis of seven randomised controlled trials including 5577 patientsNetherlands Heart Journal, 2017
- Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trialThe Lancet, 2016